Merck absorbs $200 million in tariff costs into its earnings and full-year outlook

5 months ago 19

ARTICLE AD BOX

Shares of Merck & Co. were headed higher in early Thursday trading, after the drugmaker extended its long streak of quarterly earnings beats and held firm with its full-year outlook despite expected tariff costs.

Read Entire Article

Merck absorbs $200 million in tariff costs into its earnings and full-year outlook

ARTICLE AD BOX

Related

A dividend-paying ‘vending machine’ — this oil stock weather...

If New York or California enter a recession, the entire U.S....

How can Anthropic stand out in the AI wars? I went to a Gree...

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Netflix scuttles plans to add six previously announced games...

OpenAI co-founder John Schulman has left Anthropic after les...

Steam will label early access games that haven't been update...

‘I didn’t want to spend time with my children. I was just go...